Our vision
To be global leaders discovering what causes diseases, how to slow, cure and prevent. We host scientists who see beyond prevailing dogma, who have novel but unproven hypotheses and who have an insatiable appetite to explore the unexplored.
Our research
We are seamless, studying genes-to-populations, supporting student-scientists-to-professors, integrating patient consumers-with-doctors and hosting volunteers-to-technology specialists. A shared-responsibility model to improve the lives of Australians living with disease, sooner.
Our facilities
We host state-of-the-art technology platforms in contemporary certified PC2 facilities, home to ~300 scientists.
Our focus areas
Our research encompasses four focus areas, or areas of strength, including vascular and metabolic disorders, inflammation, infectious disease and wounds, neurodegenerative disorders and cancer.
Vascular and Metabolic Disorders
We are identifying new treatments for blood vessel disorders and investigating blood vessel growth and function to treat age-associated cancers, blood-vessel inflammatory disorders, energy disorders, liver disorders and infectious diseases.
Inflammation, Infectious Disease and Wounds
We are developing ways to stop the decline in immune system function with ageing, using the immune system to treat arthritis and adult cancers.
Neurodegenerative and Pain
We are exploring new approaches for preventing and treating Alzheimer’s disease, where we’re hoping to slow cognitive decline significantly.
Cancer
We’re researching interventions for age-associated cancers, focusing on how the immune system influences cancer risk and disease progression.
CurtinMRI in the news
CurtinMRI welcomes new Director 🎉
CurtinMRI is thrilled to announce the appointment of our new Director, Professor Nina Tirnitz-Parker.
Lions Cancer Institute supports the future of medical research at CurtinMRI
CurtinMRI celebrated a milestone for melanoma research with the establishment of the Lions Cancer Institute Colin Beauchamp and Sue Goddard…
CurtinMRI and Red Cross Lifeblood join forces
CurtinMRI and Australian Red Cross Lifeblood are joining forces to develop a new faecal transplant capsule for Australian clinical trials.
Funding boost for innovative gene therapies for difficult to treat diseases
CurtinMRI’s Prof Oliver Rackham has been awarded a $2.69 million dollar grant, includes the development of protein-based gene therapies to…
Subscribe for updates
Stay up-to-date with our latest news on research, community and events.
Support CurtinMRI
Whether you are an individual, foundation, corporate or service provider, your donation – large or small – will further support our four key research areas as we strive to be bold and innovative and improve the quality of life for countless Australians.
